Phase II Study of Temozolomide Plus Thalidomide for the Treatment of Metastatic MelanomaWen-Jen Hwu, Alan N. Houghton, Philip O. Livingston et al.|Journal of Clinical Oncology|2003Cited by 141
Temozolomide plus thalidomide in patients with brain metastases from melanomaWen‐Jen Hwu, Alan N. Houghton, Eric Lis et al.|Cancer|2005Cited by 102
Phase II study of temozolomide plus pegylated interferon‐α‐2b for metastatic melanomaWen‐Jen Hwu, Alan N. Houghton, Katherine S. Panageas et al.|Cancer|2006Cited by 49
A phase II study of temozolomide (TMZ) and pegylated interferon α-2b (PGI) in the treatment of advanced melanomaSusan E. Krown, Jedd D. Wolchok, Wen-Jen Hwu et al.|Journal of Clinical Oncology|2004Cited by 2
A phase II study of temozolomide (TMZ) and pegylated interferon α-2b (PGI) in the treatment of advanced melanomaSusan E. Krown, Jedd D. Wolchok, Wen-Jen Hwu et al.|Journal of Clinical Oncology|2004Cited by 0